Sei Investments »

Inhibikase Therapeutics shares owned by Sei Investments

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Sei Investments from 13F filings

Historical chart of Sei Investments investment in Inhibikase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by Sei Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by Sei Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $81k 48k 1.68

More positions owned by Sei Investments

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Broadcom (AVGO)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Ishares Tr Core Msci Intl (IDEV)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)

View all positions for Sei Investments

Top funds holding Inhibikase Therapeutics

Sands Capital Ventures
Soleus Capital Management
Fairmount Funds Management
Trails Edge Capital Partners
ADAR1 Capital Management
BlackRock
Blackstone Group
Siren
Commodore Capital
Vanguard Group
Vanguard Capital Management
Saturn V Capital Management
Kalehua Capital Management
Squadron Capital Management
Millennium Management

View all funds holding Inhibikase Therapeutics